Top Markets
Coin of the day
Vicapsys Life Sciences, Inc. Vicapsys Life Sciences, Inc.

Vicapsys Life Sciences, Inc.

VICP
株式のランク #25709
Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive... Vicapsys Life Sciences, Inc. is primarily focused on bringing its exclusive VICAPSYN product to market, guiding it through development and commercialization. This product's intended application is within the field of transplantation, specifically for various transplant therapies and associated stem-cell uses. Additionally, the company is advancing the development of VYBRIN, a compound based on CXCL12. VYBRIN is being investigated for multiple purposes: preventing the formation of post-surgical adhesions following abdominal operations, coating implantable medical devices and other implants to inhibit fibrosis, and promoting wound healing, with a particular emphasis on diabetic ulcers. The firm, originally incorporated in 1997, transitioned its name from Phage Therapeutics International, Inc. to Vicapsys Life Sciences, Inc. in September 2017. Its operations are headquartered in Suwanee, Georgia.
株価
$1.45
最終同期: 2026-08-19
時価総額
$46.94M
変化(1日)
0.00%
変化(1年)
-18.08%
US
取引 Vicapsys Life Sciences, Inc. (VICP)

カテゴリー

Vicapsys Life Sciences, Inc.(VICP)の株価履歴
終値の最高値: $1.45 (2026-08-01)

終値の最安値: $4.00K (1998-02-01)
Vicapsys Life Sciences, Inc. の株価履歴(1998 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 1.38%
2025 -14.29%
2024 154.87%
2023 174.65%
2022 -50.00%
2021 33.33%
2020 0.00%
2019 -55.29%
2018 -6.80%
2017 -28.00%
2016 3,025.00%
2015 0.00%
2014 22.18%
2013 -67.67%
2012 -34.58%
2011 -94.15%
2010 -77.91%
2009 -6.88%
2008 -58.50%
2007 926.57%
2006 -33.53%
2005 -50.30%
2004 -58.93%
2003 -84.01%
2002 -89.45%
2001 44.98%
2000 27.56%
1999 44.30%
1998 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.33 -18.49%
AU
$761.87 8.65%
CH
$130.43 397.46%
US